Jonathan D. Root

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Menlo Park, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nathan Salha, as Attorney-in-Fact for Jonathan D. Root
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jonathan D. Root

Form 4 holding Director, 10%+ Owner

eFFECTOR Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,384,301
Estimated value
$2,659,079
Report date
02 Dec 2021
Price
$0.6065
Ownership
Directly owned by USVP X
Form 4 holding Director, 10%+ Owner

eFFECTOR Therapeutics, Inc.

Security class
Common Stock
Shares / value
140,261
Estimated value
$85,068
Report date
02 Dec 2021
Price
$0.6065
Ownership
Directly owned by AFF X
Form 4 holding Director

Inari Medical, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
19 Feb 2025
Price
$0.4569
Ownership
Direct
Form 4 holding Director

Inari Medical, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
19 Feb 2025
Price
$0.4569
Ownership
Directly Owned by Spouse
Form 4 holding Director

Silverback Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
18,000
Estimated value
Report date
10 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CARLSMED, INC.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
24 Jul 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CARLSMED, INC.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
24 Jul 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CARLSMED, INC.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
24 Jul 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omada Health, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
09 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omada Health, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
09 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omada Health, Inc.

Security class
Series C-1 Preferred Stock
Shares / value
0
Estimated value
Report date
09 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omada Health, Inc.

Security class
Series C Preferred Stock
Shares / value
0
Estimated value
Report date
09 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Omada Health, Inc.

Security class
Series D Preferred Stock
Shares / value
0
Estimated value
Report date
09 Jun 2025
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jonathan D. Root

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .